Soleno Therapeutics INC
SEC CIK 1484565 · SLNO · last insider filing 2026-05-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hahn Mark W | Director | filed 2025 - 2026 |
| Pauls Matthew | Director | filed 2023 - 2026 |
| Anish Bhatnagar | Director · See Remarks | filed 2014 - 2026 |
| Bir Dawn Carter | Director | filed 2024 - 2026 |
| Volck Birgitte | Director | filed 2019 - 2026 |
| Sinclair Andrew | Director | filed 2018 - 2026 |
| Harris William G | Director | filed 2014 - 2025 |
| Mario Ernest | Director | filed 2014 - 2024 |
| Melincoff Gwen A | Director | filed 2019 - 2023 |
| Collinson Stuart J | Director | filed 2017 - 2020 |
| Dalal Rajen | Director | filed 2016 - 2018 |
| Shah Mahendra | Director | filed 2017 - 2018 |
| Glasheen James Walter | Director | filed 2017 - 2018 |
| Engelsen Steinar J | Director | filed 2014 - 2018 |
| Engleman Edgar | Director | filed 2014 - 2018 |
| Kirnon Stephen | Director | filed 2014 - 2018 |
| O'Toole David D | Director · See Remarks | filed 2014 - 2017 |
| Alexander W James | Director | filed 2014 - 2016 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Yen Kristen | Vice President, Clinical Opera | filed 2015 - 2026 |
| Manning Meredith | Chief Commercial Officer | filed 2024 - 2026 |
| Hirano Patricia C | See Remarks | filed 2019 - 2026 |
| Norrett Kevin | Chief Business Officer | filed 2025 - 2026 |
| Fulk Jennifer | CHIEF FINANCIAL OFFICER | filed 2026 - 2026 |
| Joshi Manher | Chief Development Officer | filed 2025 - 2026 |
| Huang Michael F. | Sr. VP of Clinical Development | filed 2024 - 2026 |
| Mackaness James H | Chief Financial Officer | filed 2019 - 2026 |
| Urbanski Raymond W. | CHIEF DEVELOPMENT OFFICER | filed 2024 - 2024 |
| Wolter Jonathan | Chief Financial Officer | filed 2018 - 2019 |
| Wondka Anthony | VP of Research and Development | filed 2014 - 2016 |
| Ebbers Ed | See Remarks | filed 2015 - 2015 |
| Phelps Gina | Vice President of Sales | filed 2014 - 2015 |
| Nabhan Antoun | See Remarks | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.